The analysis of the treatment outcomes for endometrial cancer IA stage G1 showed that the methylation level of CDO1 and CDH13 genes may help to predict a positive treatment outcome (complete response) with high accuracy (AUC = 0.96). The gene discussed is CDO1; the disease is endometrial cancer.